Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III study
Taking massive doses of glutathione often leads to waste
In addition, they investigated the suitability of L-K6 antimicrobial peptide to target the cell surface of MCF-7 cells
High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine
This breadth of action distinguishes it from growth factors with a narrow receptor focus and helps explain experimentally observed tissue protection across different organ systems
ARA-290 (cibinetide) is currently investigational and not approved by the FDA for routine therapeutic use
US$ 20.43
US$ 26.87
US$ 28.31
US$ 27.61
US$ 28.26
